Comparison 10. Ciprofloxacin (500 mg twice daily) with infliximab versus placebo with infliximab.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Failure to achieve clinical response at week 12 | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
3 Withdrawal due to adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |